MIRA INFORM REPORT
|
Report Date : |
20.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
BIOTEQUE CORPORATION |
|
|
|
|
Registered Office : |
5FL.-6, No.23, Sec.1, Chang-An
E. Rd., |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
13.11.1991 |
|
|
|
|
Com. Reg. No.: |
86306206 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and sales of medical supplies |
|
|
|
|
No. of Employees
: |
About 350 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 250,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
5FL.-6, No.23, Sec.1, Chang-An E. Rd.,
Taipei 104, Taiwan, R.O.C. |
|
Supplied Address: |
|
|
Telephone Number: |
+886-2-2571-0269 |
|
Fax Number: |
|
|
E-mail: |
Notes: Subject’s exact name and address are as above.
|
Credit Rating: |
|
|
Credit Opinion: |
|
Registered Name: |
Bioteque Corporation |
|
Registered Address: |
5FL.-6, No.23, Sec.1, Chang-An E. Rd., Taipei 104, Taiwan, R.O.C. |
|
Date of Foundation: |
|
|
Registration Number: |
86306206 |
|
Registry: |
Department of Commerce, Ministry of Economic Affairs, R.O.C. |
|
Registered Capital: |
NTD 1,200,000,000 (USD 40,680,000) (As of 2012.04, 1 NTD = 0.0339 USD) |
|
Paid-up Capital: |
NTD 782,769,360 (USD 26,535,881) |
|
Legal Representatives: |
Zongli Cai |
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed at Stock
Exchange: |
Yes TPO:4107 |
|
Date of Last
Annual Return: |
Subject was incorporated on
Change of Name
|
Former Chinese Name |
邦拓生物科技股份有限公司 |
|
Current Chinese Name |
邦特生物科技股份有限公司 |
Awards
|
Year |
Awards |
|
2008 |
Blue chip
importer and exporter |
|
2009 |
Blue chip
importer and exporter |
|
2010 |
Blue chip
importer and exporter |
Standard of Blue
chip importer and exporter
Unit: USD
|
Year |
Amount |
|
2008 |
19,000,000 |
|
2009 |
15,000,000 |
|
2010 |
20,000,000 |
|
Name |
Subscription
Shares |
|
Zongli Cai |
3,909,000 |
|
Mingzhong Li |
|
|
1,582,313 |
|
|
Bangyan Zhang |
1,002,648 |
|
Excelsior Medical Co., Ltd. |
1,545,000 |
|
Junyao Lin |
2,600,000 |
|
Hailu Chen |
828,835 |
|
Yixun Li |
1,412,928 |
|
Shiguang Lv |
2,428,984 |
|
King Polytechnic Engineering Co., Ltd.) |
709,519 |
|
Qinyi Li |
422,567 |
The information above is that of subject’s major shareholders.
Branch
|
Branch
Registered Number |
28971553 |
|
Branch Name |
Yilan Branch |
|
Branch Manager |
Yixun Li |
|
Branch Address |
No. 5, Ziqiang
Road, Longde Lane, Suao Town, Yilan County, Taiwan |
|
Date of
Incorporation |
|
Core
Management
|
1 |
|
|
Name |
Zongli Cai |
|
Position |
President |
|
2 |
|
|
Name |
Mingzhong Li |
|
Position |
Vice President |
|
3 |
|
|
Name |
Bangyan Zhang |
|
Position |
Director |
|
4 |
|
|
Name |
Mingting Wang |
|
Position |
Director |
|
5 |
|
|
Name |
Junyao Lin |
|
Position |
Director |
|
6 |
|
|
Name |
Hailu Chen |
|
Position |
Director |
|
7 |
|
|
Name |
Yixun Li |
|
Position |
Director |
|
8 |
|
|
Name |
Shiguang Lv |
|
Position |
Supervisor |
|
9 |
|
|
Name |
Zhenpan Hong |
|
Position |
Supervisor |
|
10 |
|
|
Name |
Qinyi Li |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 350 employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
5FL.-6, No.23,
Sec.1, Chang-An E. Rd., Taipei 104, Taiwan, R.O.C. |
|
Plant Area |
Production
Information
l
Subject is a manufacturer of medical supplies
l
It is introduced that subject has obtained the certification
of GMP, ISO9001, ISO13485, CE0434 and FDA 510 (K), etc
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
CF01011 |
|
|
F108031 |
|
|
F208031 |
|
|
ZZ99999 |
Besides licensed business, all other business
items those are not banned or restricted. |
l
Subject’s products are mainly made of TPU, Silicon,
PTFE, PFA, Nylon, etc
l
Subject purchases both at home and abroad.
Sales
Information
l
The subject is mainly engaged in sales of medical
supplies including Kidney tube, puncture needle, Precision infusion set, Senior
medical soft bag, urine bag, canal and other Medical personnel supplies, etc
l
Subject’s products are applied to nephrology, urology, radiology,
Cardiology, Respiratory Therapy, Critical Care, iv administration therapy
and molding parts,
etc
l
Subject’s products are both sold in domestic and
overseas market and it is introduced that subject exports to over 40 countries
in America, Europe, Asia and Africa.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials, etc |
COD, Credit Sales, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials, etc |
CBD, etc |
100% |
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Medical supplies |
CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Medical supplies |
CBD, etc |
100% |
Unit: NTD/000
|
|
|
|
|
Cash And Cash
Equivalents |
78,472 |
88,758 |
|
Net Notes
Receivable |
31,018 |
27,238 |
|
Net Accounts
Receivable |
112,892 |
114,783 |
|
Other Financial
Assets-Current |
3 |
2 |
|
Current Assets |
624,122 |
699,009 |
|
Inventories-selling
industry |
1,144 |
. |
|
Inventories |
105,221 |
106,806 |
|
Inventories-manufacturing |
104,077 |
106,806 |
|
20,437 |
21,625 |
|
|
goods in
progress |
24,735 |
20,637 |
|
Raw materials |
51,733 |
60,475 |
|
Materials and
supplies intransit |
7,172 |
4,069 |
|
The allowance
for depreciation and sluggish stock losses |
. |
. |
|
Other Current
Assets |
9,773 |
8,054 |
|
Restricted
Current Assets |
1,201 |
1,201 |
|
Other Current
Assts-Others |
8,572 |
6,853 |
|
Changes in the
fair value of the financial assets on profit and loss-current |
286,743 |
353,368 |
|
Investment |
266,243 |
227,676 |
|
Long-Term
Investments at equity |
266,243 |
227,676 |
|
Other financial
Assets-Non Current |
674 |
701 |
|
Financial Assets
for sales-Non current |
1,127 |
2,255 |
|
Fund and
Investment |
268,044 |
230,632 |
|
Land |
100,334 |
100,334 |
|
Building and
structure |
396,041 |
393,121 |
|
Machine
Equipment |
438,724 |
433,720 |
|
Transporting
Equipment |
4,237 |
3,722 |
|
18,722 |
14,181 |
|
|
Total Fixed
assets cost |
1,015,767 |
1,002,995 |
|
Machinery Revaluation
Increments |
. |
. |
|
accumulated
depreciation |
-298,346 |
-262,353 |
|
Net Fixed Assets |
733,239 |
753,901 |
|
Cost and value
through revaluation totals |
1,015,767 |
1,002,995 |
|
Unfinished
project and equipment funds in advance |
15,818 |
13,259 |
|
Unfinished
project |
. |
156 |
|
Equipment Funds
In Advance |
15,818 |
13,103 |
|
Other devices |
57,709 |
57,917 |
|
Deferred Pension
Costs |
. |
374 |
|
Total Intangible
Assets |
. |
374 |
|
Deferred charges |
2,832 |
1,060 |
|
Total Other
Assets |
2,832 |
1,060 |
|
Total Assets |
1,628,237 |
1,684,976 |
|
Shortterm
Borrowing |
. |
. |
|
19,728 |
29,873 |
|
|
39,197 |
32,778 |
|
|
Income Tax
Payable |
1,535 |
18,857 |
|
Accrued Charge |
48,384 |
47,443 |
|
Financial
liabilities at fair value through profit or loss-current |
. |
509 |
|
Current
Liabilities; |
167,097 |
167,683 |
|
Other payables |
3,912 |
4,319 |
|
. |
. |
|
|
Payables on
equipment |
3,912 |
4,319 |
|
Long-Term
Liabilities -Current Portion |
32,650 |
17,650 |
|
Long-Term
loan-Current Portion |
32,650 |
17,650 |
|
Other Current
Liabilities |
21,691 |
16,254 |
|
172,475 |
205,125 |
|
|
LongTerm Bank
Loans |
172,475 |
205,125 |
|
Longterm
Liabilities |
172,475 |
205,125 |
|
Pension prepared/
accrued pension liabilities |
2,462 |
4,785 |
|
10 |
. |
|
|
Deferred Income
Tax |
36,289 |
41,329 |
|
Deferred Income
Tax Liabilities-Non
Current |
36,289 |
41,329 |
|
Other
Liabilities-Others |
8,941 |
22,831 |
|
Other Liabilities-Others |
8,941 |
22,831 |
|
Total Other
Liabilities |
47,702 |
68,945 |
|
Total
Liabilities |
387,274 |
441,753 |
|
Common Stock |
782,769 |
782,769 |
|
782,769 |
782,769 |
|
|
83,003 |
83,003 |
|
|
76,104 |
76,104 |
|
|
6,899 |
6,899 |
|
|
Total capital
reserve |
83,003 |
83,003 |
|
105,507 |
88,248 |
|
|
Special Reserve |
53,270 |
27,603 |
|
Unappropriated
Retained Earnings |
259,643 |
314,870 |
|
Accumulated
Profit Or Loss |
259,643 |
314,870 |
|
Total Retained Earnings |
418,420 |
430,721 |
|
Cumulative
Translation Adjustment |
-31,816 |
-40,892 |
|
Share Capital-
share premium |
. |
-2,093 |
|
Unrealized gain
or loss on financial instrument |
-11,413 |
-10,285 |
|
Total
Shareholders' equity other adjustment |
-43,229 |
-53,270 |
|
Equivalent
Shares of Outstandings of Advance Receipts for Common Stock (Unit: Share) |
. |
. |
|
Number of
Treasury Stock Acquired by Parent Company and Subsidiaries (unit:
Share) |
. |
. |
|
Total
shareholders' equity |
1,240,963 (USD 42,068,646) |
1,243,223 (USD 42,145,260) |
(As of 2012.04, 1 NTD =
0.0339 USD)
Unit: NTD/000
|
|
2011 |
2010 |
|
759,437 (USD 25,744,914) |
821,623 (USD 27,853,020) |
|
|
Net sales
revenue |
759,437 |
821,623 |
|
Total sales
revenue |
759,956 |
826,161 |
|
sales returns |
519 |
4,538 |
|
sales discounts
and allowances |
. |
. |
|
Total Cost Of
Sales |
519,937 |
512,613 |
|
cost of goods
sold; |
519,937 |
512,613 |
|
Operating margin
(Loss) |
239,500 |
309,010 |
|
133,414 |
133,388 |
|
|
Distribution
Cost |
49,250 |
55,674 |
|
General
Andadministrative Expenses |
36,876 |
36,183 |
|
Research And
Development Expenses |
47,288 |
41,531 |
|
Net Operating
Profit (loss) |
106,086 |
175,622 |
|
Non-operating revenue
and profit |
36,805 |
36,155 |
|
101 |
577 |
|
|
Income From
Investment; |
898 |
2,624 |
|
Investment
Profit Recognized Under Equity Method |
898 |
2,624 |
|
Income Gain |
. |
. |
|
Gains on Sale of
Fixed Assets |
. |
99 |
|
Foreign Exchange
Gain |
5,131 |
. |
|
Financial assets
evaluation interests |
1,970 |
1,415 |
|
Financial
liabilities evaluation interests |
509 |
. |
|
Miscellaneous
Income |
28,196 |
31,440 |
|
Non-operating expenses
and losses |
3,460 |
13,875 |
|
3,460 |
3,232 |
|
|
. |
. |
|
|
investment loss |
. |
. |
|
Other investment
loss |
. |
. |
|
Loss On Exchange |
. |
10,118 |
|
Financial assets
evaluation loss |
. |
. |
|
Financial
Liabilities evaluation loss |
. |
509 |
|
Miscellaneous
Expenses |
. |
16 |
|
Income (loss)from
continuing operations before income tax |
139,431 |
197,902 |
|
Income tax
expense (benefit) |
10,834 |
25,315 |
|
Income tax
expense (benefit) |
10,834 |
25,315 |
|
Income (lossrom
continuing operations |
128,597 |
172,587 |
|
Net income
(loss) |
128,597 (USD 4,359,438) |
172,587 (USD 5,850,699) |
|
Basic EPS (Unit:
NTD) |
1.64 |
2.20 |
|
Diluted EPS
(Unit: NTD) |
1.63 |
2.19 |
(As of 2012.04, 1 NTD =
0.0339 USD)
Subject declined to disclose its bank details; from other source we can
not obtain the relevant information, either.
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of reporting,
no existing or latent litigation of the subject has been found.
|
Department |
Sales department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.89 |
|
UK Pound |
1 |
Rs.83.18 |
|
Euro |
1 |
Rs.68.06 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.